| Issue | Title | |
| Vol 10, No 3 (2017) | Decision modelling for the evaluation of diabetes outcomes | Abstract PDF (Rus) |
| A. A. Mosikian, W. Zhao, T. L. Galankin, A. S. Kolbin | ||
| Vol 8, No 1 (2015) | DEFINING THE MAIN TYPES OF RESEARCH AND DEVELOPMENT FOR PURPOSES OF SHAPING STATE R&D POLICY IN RUSSIA AND IN OECD COUNTRIES | Abstract PDF (Rus) |
| O. V. Bogacheva, O. A. Feoktistova | ||
| Vol 11, No 3 (2018) | Determination of a willingness-to-pay threshold and decision-making in financing the healthcare technologies | Abstract PDF (Rus) |
| T. S. Teptsova, T. P. Bezdenezhnyh, V. K. Fedyaeva, N. Z Musina, G. R. Hachatryan, V. V. Tarasov | ||
| Vol 12, No 4 (2019) | Developing clinical guidelines and assessing the quality of medical care using the RAND/UCLA method | Abstract PDF (Rus) |
| O. O. Buzuverova, V. K. Fedyaeva, O. A. Sukhorukikh | ||
| Vol 17, No 4 (2024) | Development of a classification of anesthetic management methods and protocols for calculating financial costs | Abstract PDF (Rus) |
| D. V. Lukyantseva, J. A. Agafonova, V. V. Omelyanovskiy, S. A. Kovaleva, D. V. Fedyaev, I. N. Pasechnik, V. V. Schukin, D. S. Blinov, A. B. Abrosimov | ||
| Vol 5, No 3 (2012) | DEVELOPMENT OF A COMPUTER MODULE FOR FORECASTING AND ESTIMATING EFFICIENCY OF BASIC THERAPY OF MULTIPLE SCLEROSIS | Abstract PDF (Rus) |
| F. A. Khabirov, D. Kh. Shakirova, O. A. Dun, T. I. Khaibullin | ||
| Vol 13, No 4 (2020) | Development of a method for calculation of demand for medical personnel in the healthcare of the Russian Federation, using a mathematical model | Abstract PDF (Rus) |
| V. V. Omelyanovsky, T. V. Semenova, D. V. Lukyantseva, D. V. Fedyaev, E. A. Shalaeva | ||
| Vol 14, No 1 (2021) | Development of a method for the analysis of the lists of medicines and its application for the analysis of the lists of medicines in Russia, England, and Italy | Abstract PDF (Rus) |
| V. A. Lemeshko, K. I. Matrenin, V. V. Omelyanovskiy, Yu. V. Vasilyeva, G. R. Khachatryan, L. A. Kolganov | ||
| Vol 16, No 1 (2023) | Development of a verified osteoarthritis risk scale based on a cross-sectional study of clinical and anamnestic parameters and pharmacological anamnesis of patients | Abstract PDF (Rus) |
| I. Yu. Torshin, А. М. Lila, N. V. Zagorodniy, А. G. Nazarenko, О. N. Tkacheva, Е. N. Dudinskaya, L. I. Alekseeva, Е. А. Taskina, I. V. Sarvilina, О. А. Shavlovskaya, A. B. Danilov, Т. B. Minasov, А. N. Galustyan, S. I. Malyavskaya, А. N. Gromov, Е. Yu. Egorova, L. V. Vasilyeva, E. F. Evstratova, I. V. Gogoleva, L. E. Fedotova, М. I. Udovika, V. A. Maximov, А. S. Povzun, О. А. Gromova | ||
| Vol 16, No 4 (2023) | Development of approaches to the evaluation of pharmacotherapy effectiveness for chronic hepatitis C | Abstract PDF (Rus) |
| I. A. Narkevich, E. A. Tsitlionok | ||
| Vol 16, No 2 (2023) | Development of methodological approaches to the formation of a risk-based model to minimize the prevalence of adverse reactions in drug application in medical organizations of Moscow | Abstract PDF (Rus) |
| E. V. Kuznetsova, M. V. Zhuravleva, I. A. Mikhailov, T. I. Kurnosova | ||
| Vol 14, No 4 (2021) | Development of the system of state financing of Compulsory Health Insurance | Abstract PDF (Rus) |
| А. V. Larionov, S. V. Russkikh, S. V. Maslennikov | ||
| Vol 12, No 3 (2019) | Diagnosis-related groups and payments for the treatment of malignant neoplasms in the model of 2019 | Abstract PDF (Rus) |
| D. V. Fedyaev , V. V. Omelyanovskiy , M. L. Lazareva , Yu. V. Seryapina, Yu. A. Ledovskikh | ||
| Vol 15, No 4 (2022) | Dietary factors influencing the COVID-19 epidemic process | Abstract PDF (Eng) |
| S. V. Ponomarenko | ||
| Vol 14, No 1 (2021) | Differences in the standardization of medicinal products based on extracts of chondroitin sulfate | Abstract PDF (Rus) |
| O. A. Gromova, I. Yu. Torshin, B. Ts. Zaychik, E. V. Shikh, A. O. Ruzhitskiy, A. N. Galustyan, I. S. Sardaryan, I. V. Sarvilina | ||
| Online First | Differential chemoproteomic analysis of RRS-1 candidate molecule and molecules of several nonsteroidal anti-inflammatory drugs | Abstract PDF (Rus) |
| P. A. Galenko-Yaroshevsky, I. Yu. Torshin, A. N. Gromov, O. A. Gromova, K. F. Suzdalev, R. A. Murashko, A. V. Zelenskaya, A. V. Zadorozhniy, T. R. Glechyan, G. V. Simavonyan, E. M.I. Muhammad | ||
| Vol 17, No 3 (2024) | Differential chemoproteomic analysis of RRS-1 candidate molecule and molecules of several nonsteroidal anti-inflammatory drugs | Abstract PDF (Rus) |
| P. A. Galenko-Yaroshevsky, I. Yu. Torshin, A. N. Gromov, O. A. Gromova, K. F. Suzdalev, R. A. Murashko, A. V. Zelenskaya, A. V. Zadorozhniy, T. R. Glechyan, G. V. Simavonyan, E.M. I. Muhammad | ||
| Vol 11, No 4 (2018) | Direct medical costs of using enzalutamide or abiraterone in chemotherapy-naïve patients with metastatic castration resistant prostate cancer | Abstract PDF (Rus) |
| N. A. Avxentyev, A. S. Makarov, M. Yu. Frolov | ||
| Vol 10, No 1 (2017) | DISCUSSION | Abstract PDF (Rus) |
| Anna Yarvits | ||
| Vol 16, No 3 (2023) | Disease-modifying osteoarthritis drugs (DMOADs): new trends in osteoarthritis therapy | Abstract PDF (Rus) |
| O. A. Shavlovskaya, О. А. Gromova, A. Yu. Kochish, Yu. D. Yukhnovskaya, I. D. Romanov, I. A. Bokova | ||
| Vol 16, No 4 (2023) | DMOADs and DMARDs in the treatment of patients with joint and spine diseases | Abstract PDF (Rus) PDF (Eng) |
| O. A. Shavlovskaya | ||
| Vol 13, No 1 (2020) | Drug provision and health technology assessment in France | Abstract PDF (Rus) |
| V. V. Omelyanovskiy, A. V. Nikitina, V. A. Lemeshko, G. R. Khachatryan | ||
| Vol 15, No 3 (2022) | Drug therapy for obesity in the Russian Federation: pharmacoepidemiological study | Abstract PDF (Rus) |
| V. V. Strizheletsky, Yu. М. Gomon, Е. А. Spichakova, А. S. Kolbin, А. А. Kalyapin, S. А. Makarov, А. B. Lomiya, F. М. Sultanova | ||
| Vol 9, No 3 (2016) | DRUGS PROVIDED TO BREAST CANCER PATIENTS WITHIN THE STATE PROGRAMS OF DRUG SUPPLY | Abstract PDF (Rus) |
| M. V. Avxentyeva, V. I. Bogin, E. V. Derkach, V. V. Omelyanovskiy, M. B. Stenina, A. V. Tarakanov, M. Yu. Frolov | ||
| Vol 17, No 4 (2024) | Dynamics of anticancer drug use in Russian hospitals: a five-year retrospective analysis | Abstract PDF (Rus) |
| J. A. Agafonova, V. V. Omelyanovskiy | ||
| Vol 5, No 1 (2012) | DYNAMICS OF PREFERENTIAL MAINTENANCE OF CITIZENS WITH ANTIHYPERTENSIVE DRUGS AT THE EXPENSE OF THE REGIONAL BUDGET | Abstract PDF (Rus) |
| I. I. Lavrentyeva, A. I. Khokhlov, I. N. Kagramanyan, T. A. Gorokhova | ||
| Vol 12, No 2 (2019) | Dynamics of prices and consumption of anticancer drugs in Russia after their generics and biosimilars became available | Abstract PDF (Rus) |
| F. V. Gorkavenko, A. V. Nikitina, E. S. Saibel’, M. V. Avksent’eva, M. V. Sura, D. V. Fedyaev | ||
| Vol 9, No 3 (2016) | EARLY HEALTH TECHNOLOGIES ASSESSMENT — NEW APPROACH TO IMPROVING THE EFFICIENCY OF THE MEDICAL TECHNOLOGY DEVELOPMENT PROCESS | Abstract PDF (Rus) |
| N. Z. Musina, V. V. Omelyanovskiy, A. V. Krasheninnikova | ||
| Vol 17, No 3 (2024) | Economic analysis of implementing Systemic Coronary Risk Estimation (SCORE2) scale and long-term consequences | Abstract PDF (Rus) |
| E. O. Kurilovich, A. V. Nikitina, I. V. Sorokovikov | ||
| Vol 7, No 2 (2014) | ECONOMIC ANALYSIS OF USE OF IMMUNOCORRECTIVE PREPARATIONS FOR PREVENTION OF OFTEN RESPIRATORY INFECTIONS AND THEIR COMPLICATIONS AT CHILDREN OF SCHOOL AGE | Abstract PDF (Rus) |
| R. V. Maiorov, D. P. Derbenev | ||
| Vol 15, No 3 (2022) | Economic aspects of using new chemotherapy regimens for multidrug and extensively drugresistant tuberculosis | Abstract PDF (Rus) |
| А. V. Kukurika | ||
| Vol 7, No 1 (2014) | ECONOMIC ASSESSMENT OF MAGNESIUM DEFICIENCY CORRECTION FOR BASIC THERAPY EFFICACY OF UNCONTROLLED ASTHMA IN CHILDREN | Abstract PDF (Rus) |
| V. I. Petrov, I. N. Shishimorov, O. V. Magnitskaya, Ju. V. Ponomareva | ||
| Vol 10, No 2 (2017) | ECONOMIC ASSESSMENT OF THE EFFECTIVENESS AND SAFETY OF THE COMMONLY PRACTICED PERIOPERATIVE ANTIBIOTIC PROPHYLAXIS (BASED ON AN EARLIER EPIDEMIOLOGICAL SURVEY OF MULTIDISCIPLINARY HOSPITALS) | Abstract PDF (Rus) |
| Yu. M. Gomon, A. S. Kolbin, S. V. Sidorenko, A. M. Kuzhel’, A. V. Repina, Yu. V. Lobzin, Yu. E. Balykina | ||
| Vol 10, No 2 (2017) | ECONOMIC ASSESSMENT OF THE EFFECTIVENESS AND SAFETY OF THE COMMONLY PRACTICED PERIOPERATIVE ANTIBIOTIC PROPHYLAXIS (BASED ON AN EARLIER EPIDEMIOLOGICAL SURVEY OF MULTIDISCIPLINARY HOSPITALS) | Abstract PDF (Rus) |
| Yu. M. Gomon, A. S. Kolbin, S. V. Sidorenko, A. M. Kuzhel’, A. V. Repina, Yu. V. Lobzin, Yu. E. Balykina | ||
| Vol 11, No 3 (2018) | Economic barriers restraining the production of therapeutic recombinant human trypsin. Use of innovative technologies to overcome them | Abstract PDF (Rus) |
| S. V. Ponomarenko | ||
| Vol 14, No 4 (2021) | Economic burden of chronic viral hepatitis C | Abstract PDF (Rus) |
| R. A. Yakhina, I. A. Lakman, D. A. Valishin, R. Kh. Bakhitova | ||
| Vol 13, No 3 (2020) | Economic burden of systemic sclerosis: systematic review | Abstract PDF (Rus) |
| D. L. Klabukova, V. S. Krysanova, T. N. Ermolaeva, M. V. Davydovskaya, K. A. Kokushkin | ||
| Vol 15, No 3 (2022) | Economic burden of the novel coronavirus infection: a systematic review | Abstract PDF (Rus) |
| V. M. Timiryanova, I. A. Lakman, N. Sh. Zagidullin, D. F. Gareeva | ||
| Vol 13, No 1 (2020) | Economic challenges of oncological diseases’ pharmacotherapy | Abstract PDF (Rus) |
| E. A. Ushkalova, S. K. Zyryanov, I. A. Gopienko | ||
| Vol 12, No 1 (2019) | Economic consequences of healthcare optimization for IBD patients in the Republic of Tatarstan | Abstract PDF (Rus) |
| T. P. Bezdenezhnykh, D. V. Fedyaev, G. R. Khachatryan, G. G. Arutyunov, K. V. Gerasimova | ||
| Vol 17, No 4 (2024) | Economic effectiveness of fixed-dose combination of alogliptin and pioglitazone in diabetes mellitus treatment | Abstract PDF (Rus) |
| S. К. Zyryanov, I. N. Dyakov | ||
| Vol 11, No 2 (2018) | Economic evaluation of postoperative hypofractionated radiation therapy in patients with breast cancer | Abstract PDF (Rus) |
| G. V. Afonin, Yu. A. Ragulin, M. V. Avxentyeva, I. A. Gulidov, S. A. Ivanov, A. D. Kaprin | ||
| Vol 6, No 3 (2013) | ECONOMIC EVALUATION OF THE EFFECTIVENESS OF LOW MOLECULAR WEIGHT HEPARIN AND INTERMITTENT PNEUMATIC COMPRESSION IN WOMEN IN A CYCLE OF IN VITRO FERTILIZATION | Abstract PDF (Rus) |
| A. P. Momot, I. V. Molchanova, N. A. Semenova, O. P. Tomilina, E. A. Elykomov, O. G. Borisova | ||
| Vol 7, No 3 (2014) | ECONOMIC JUSTIFICATION FOR TELEHEALTH TECHNOLOGY USE FOR PREVENTIVE MEDICAL EXAMINATION OF THE POPULATION IN REMOTE REGIONS | Abstract PDF (Rus) |
| D. V. Fedyaev, V. K. Fedyaeva, V. V. Omelyanovsky | ||
| Vol 14, No 4 (2021) | Economic outcomes of centralized procurements of gene therapy for patients with orphan diseases: inherited retinal dystrophy | Abstract PDF (Rus) |
| N. А. Avxentyev, Yu. V. Makarova, V. V. Kadyshev | ||
| Vol 14, No 2 (2021) | Effect of vitamin D intake on quality of life parameters in office workers | Abstract PDF (Rus) |
| A. T. Sharman, Sh. K. Adambekov, A. A. Imandosova, G. F. Elemesova | ||
| Vol 12, No 1 (2019) | Effective search for potentially innovative scientific results in medicine | Abstract PDF (Rus) |
| M. B. Khrustalev, A. A. Maksimova | ||
| Vol 18, No 2 (2025) | Effectiveness of preliminary differential diagnosis of benign and malignant skin neoplasms using the Derma Onko Check artificial intelligence program | Abstract PDF (Rus) |
| A. I. Lamotkin, D. I. Korabelnikov, O. Yu. Olisova, I. A. Lamotkin | ||
| Vol 9, No 3 (2016) | EFFICACY AND SAFETY OF THE ORAL ANTICOAGULANTS IN THE MANAGEMENT OF VENOUS THROMBOEMBOLISM: INDIRECT COMPARISON | Abstract PDF (Rus) |
| V. I. Petrov, O. V. Shatalova, V. S. Gorbatenko, D. V. Frolov, E. A. Ponomarev, A. S. Maslakov | ||
| Vol 16, No 3 (2023) | Efficacy of alectinib in comparison with lorlatinib in patients with ALK-positive non-small cell lung cancer: pharmacoeconomic study | Abstract PDF (Rus) |
| A. S. Kolbin, Yu. M. Gomon, M. A. Proskurin, Yu. E. Balykina | ||
| 151 - 200 of 539 Items | << < 1 2 3 4 5 6 7 8 9 10 > >> | |
Browse Title Index
Popular articles
Vol 10, No 1 (2017)
Vol 17, No 3 (2024)
Vol 16, No 3 (2023)
Vol 16, No 4 (2023)
Vol 13, No 1 (2020)
Vol 14, No 4 (2021)
Keywords
COVID-19
artificial intelligence
budget impact analysis
chemotherapy
children
chondroitin sulfate
clinical and economic analysis
cost minimization analysis
cost-effectiveness analysis
cost-utility analysis
drug supply
drugs
glucosamine sulfate
health technology assessment
oncology
pharmaceutical market
pharmacoeconomic analysis
pharmacoeconomics
pharmacoepidemiology
pharmacoinformatics
quality of life
Publisher: IRBIS LLC
24 Chechersky St., Moscow 117042
Phone: +7 (495) 649 54 95
Email: digevskaya@irbis-1.ru
